ClinicalTrials.Veeva

Menu

Real-Life Study in Diabetic Macular Edema

K

Kocaeli University

Status

Completed

Conditions

Diabetic Macular Edema

Treatments

Other: Retrospective study

Study type

Observational

Funder types

Other

Identifiers

NCT05472376
MARMASIA Study Group

Details and patient eligibility

About

The goal of this study is to evaluate the real-world outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment in diabetic macular edema (DME) patients.

Full description

The study included patients who were being observed in the retina departments of 8 tertiary hospitals in the Northern Marmara Region of Turkey (Istanbul's Asian Side, Kocaeli, and Sakarya). The records of DME patients treated with an anti-VEGF agent between January 2015 and December 2018 were reviewed.

Enrollment

854 patients

Sex

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diabetic macular edema treated with intravitreal anti-VEGF injection
  • Having at least 4 or more annual examination visits

Exclusion criteria

  • Phacoemulsification surgery in the last 1 month
  • PRFK / grid / focal / micropulse in the last 4 months
  • Previous intraocular surgery (excluding PPV and phacoemulsification)

Trial design

854 participants in 5 patient groups

3-month follow-up
Treatment:
Other: Retrospective study
6-month follow-up
Treatment:
Other: Retrospective study
12-month follow-up
Treatment:
Other: Retrospective study
24-month follow-up
Treatment:
Other: Retrospective study
36-month follow-up
Treatment:
Other: Retrospective study

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems